the evolution of dengue over a decade in delhi, india

2
Journal of Clinical Virology 40 (2007) 87–88 Letter to the Editor Keywords: Dengue fever; Outbreak; ELISA; Serology The evolution of dengue over a decade in Delhi, India Sir, Delhi, the capital of India, has faced seven outbreaks of dengue virus infection due to various serotypes since 1967, with the last one in 2003 (Broor et al., 1997; Dar et al., 1999; Gupta et al., 2005). The first major epidemic of dengue hemorrhagic fever (DHF), due to dengue-2 virus in 1996 (Dar et al., 1999), led to >10,000 cases (60% of cases reported from India in 1996) with 423 deaths (National Vector Borne Disease Control Programme NVBDCP; http: //mohfw.nic.in / NVBDCP % 20WEBSITE/DENGUE1. html). Subsequently, though the virus continued to circulate, an increase in cases was seen only in 2001 (322 cases with 3 deaths; NVBDCP). In 2002, the number came down to 45. However, in 2003, Delhi witnessed another outbreak with >2800 cases and 35 casualties (NVBDCP). In the following years (2004 and 2005), though no outbreak occurred, sporadic cases continued to be reported (Gupta et al., 2006). Again, in the year 2006, Delhi faced yet another outbreak with a much higher number of cases, crossing the figure of 3000, with 65 deaths, contributing to 28% of the all dengue cases reported from all over India (NVBDCP). Our laboratory received 1110 samples for the diagnosis of dengue fever (DF). Sera were tested for dengue specific IgM antibodies, from patients with fever for 5 days. The clinical basis for diagnosing DF and DHF/dengue shock syndrome (DSS) was based on standard clinical criteria (Pan American Health Organization, 2000). Serum samples were screened by IgM-capture ELISA (PanBio, Australia) following the manufacturer’s protocol. Optical density was measured at 450 nm using an ELISA reader (Labsystems Multiskan Plus, Finland) and interpreted as per by the manufacturer’s criteria. Of 1110 samples tested, 664 (59.8%) were positive for dengue IgM antibodies. Samples peaked in October, with 525 positive out of 857 received. The predominant age group involved was 21–30 years (35.5%), followed by 11–20 years (25.6%). Males outnumbered females by 3:1, as reported earlier (Gupta et al., 2006). In 2006 of 664 seropositive cases, 142 (21.3%) presented with DHF. DHF had shown an increase >20% in 2005, com- pared to 10% in preceding years (Gupta et al., 2006). This may be because Delhi is now truly hyperendemic for dengue, with all the four serotypes co-circulating (Dar et al., 2003). Even in 2006 (data not shown) all the four serotypes of dengue virus were detected, including many mixed infections. The frequency of dengue epidemics and the proportion of DHF are known to increase with hyperendemicity (Barrera et al., 2002). This strong resurgence has led the Government of India to bring dengue under the umbrella of the National Vector Borne Disease Control Programme, which adopts a comprehensive framework to control it through vector surveillance and management, legislative measures, health education for community mobilization and inter-sectoral con- vergence. Acknowledgements We thank Mr. Ashok Saini, Ms. Shivani Saxena, Ms. Prema Nair, Mr. Salek Chand and Mr. Milan Chakraborty for excellent technical support. References Barrera R, Delgado N, Jimenez M, Valero S. Eco-epidemiological factors associated with hyper endemic dengue hemorrhagic fever in Maracay city, Venezuela. Dengue Bull 2002;26:84–95. Broor S, Dar L, Sengupta S, Chakaraborty M, Wali JP, Biswas A, Kabra SK, Jain Y, Seth P. Recent dengue epidemic in Delhi, India. In: Saluzzo JE, Dodet B, editors. Factors in the emergence of arbovirus diseases. Paris: Elsevier; 1997. p. 123–7. Dar L, Broor S, Sengupta S, Xess I, Seth P. The first major outbreak of dengue hemorrhagic fever in Delhi, India. Emerg Infect Dis 1999;5:589–90. Dar L, Gupta E, Narang P, Broor S. Co-circulation of dengue serotypes, Delhi, India. Emerg Infect Dis 2003;12(2):352–3 (Letter to the Editor). 1386-6532/$ – see front matter © 2007 Elsevier B.V. All rights reserved. doi:10.1016/j.jcv.2007.05.011

Upload: anubhav-pandey

Post on 25-Oct-2016

216 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: The evolution of dengue over a decade in Delhi, India

K

T

S

o1ad1rVhha34wfoaofiaOdab(Hbm4Pcfwa

1d

Journal of Clinical Virology 40 (2007) 87–88

Letter to the Editor

1a

wpmwEvfa2IVasev

A

Pf

R

B

B

Elsevier; 1997. p. 123–7.

eywords: Dengue fever; Outbreak; ELISA; Serology

he evolution of dengue over a decade in Delhi, India

ir,

Delhi, the capital of India, has faced seven outbreaksf dengue virus infection due to various serotypes since967, with the last one in 2003 (Broor et al., 1997; Dar etl., 1999; Gupta et al., 2005). The first major epidemic ofengue hemorrhagic fever (DHF), due to dengue-2 virus in996 (Dar et al., 1999), led to >10,000 cases (60% of caseseported from India in 1996) with 423 deaths (Nationalector Borne Disease Control Programme NVBDCP;ttp: //mohfw.nic.in / NVBDCP % 20WEBSITE/DENGUE1.tml). Subsequently, though the virus continued to circulate,n increase in cases was seen only in 2001 (322 cases withdeaths; NVBDCP). In 2002, the number came down to

5. However, in 2003, Delhi witnessed another outbreakith >2800 cases and 35 casualties (NVBDCP). In the

ollowing years (2004 and 2005), though no outbreakccurred, sporadic cases continued to be reported (Gupta etl., 2006). Again, in the year 2006, Delhi faced yet anotherutbreak with a much higher number of cases, crossing thegure of 3000, with 65 deaths, contributing to 28% of thell dengue cases reported from all over India (NVBDCP).ur laboratory received 1110 samples for the diagnosis ofengue fever (DF). Sera were tested for dengue specific IgMntibodies, from patients with fever for ≥5 days. The clinicalasis for diagnosing DF and DHF/dengue shock syndromeDSS) was based on standard clinical criteria (Pan Americanealth Organization, 2000). Serum samples were screenedy IgM-capture ELISA (PanBio, Australia) following theanufacturer’s protocol. Optical density was measured at

50 nm using an ELISA reader (Labsystems Multiskanlus, Finland) and interpreted as per by the manufacturer’s

riteria. Of 1110 samples tested, 664 (59.8%) were positiveor dengue IgM antibodies. Samples peaked in October,ith 525 positive out of 857 received. The predominant

ge group involved was 21–30 years (35.5%), followed by

D

D

386-6532/$ – see front matter © 2007 Elsevier B.V. All rights reserved.oi:10.1016/j.jcv.2007.05.011

1–20 years (25.6%). Males outnumbered females by 3:1,s reported earlier (Gupta et al., 2006).

In 2006 of 664 seropositive cases, 142 (21.3%) presentedith DHF. DHF had shown an increase >20% in 2005, com-ared to ∼10% in preceding years (Gupta et al., 2006). Thisay be because Delhi is now truly hyperendemic for dengue,ith all the four serotypes co-circulating (Dar et al., 2003).ven in 2006 (data not shown) all the four serotypes of dengueirus were detected, including many mixed infections. Therequency of dengue epidemics and the proportion of DHFre known to increase with hyperendemicity (Barrera et al.,002). This strong resurgence has led the Government ofndia to bring dengue under the umbrella of the Nationalector Borne Disease Control Programme, which adoptscomprehensive framework to control it through vector

urveillance and management, legislative measures, healthducation for community mobilization and inter-sectoral con-ergence.

cknowledgements

We thank Mr. Ashok Saini, Ms. Shivani Saxena, Ms.rema Nair, Mr. Salek Chand and Mr. Milan Chakrabortyor excellent technical support.

eferences

arrera R, Delgado N, Jimenez M, Valero S. Eco-epidemiological factorsassociated with hyper endemic dengue hemorrhagic fever in Maracaycity, Venezuela. Dengue Bull 2002;26:84–95.

roor S, Dar L, Sengupta S, Chakaraborty M, Wali JP, Biswas A, Kabra SK,Jain Y, Seth P. Recent dengue epidemic in Delhi, India. In: Saluzzo JE,Dodet B, editors. Factors in the emergence of arbovirus diseases. Paris:

ar L, Broor S, Sengupta S, Xess I, Seth P. The first major outbreak of denguehemorrhagic fever in Delhi, India. Emerg Infect Dis 1999;5:589–90.

ar L, Gupta E, Narang P, Broor S. Co-circulation of dengue serotypes,Delhi, India. Emerg Infect Dis 2003;12(2):352–3 (Letter to the Editor).

Page 2: The evolution of dengue over a decade in Delhi, India

8 f Clini

G

G

N

P

8 Letter to the Editor / Journal o

upta E, Dar L, Narang P, Srivastava VK, Broor S. Serodiagnosis of dengueduring an outbreak at a tertiary care hospital in Delhi. Indian J Med Res2005;121:36–8.

upta E, Dar L, Kapoor G, Broor S. The changing epidemiology of denguein Delhi, India. Virol J 2006;3:92.

ational Vector Borne Disease Control Programme. http://mohfw.nic.in/NVBDCP%20WEBSITE/DENGUE1.html.

an American Health Organization. Epidemiol Bull 2000;21(June (2)).

Anubhav PandeyKavita Diddi

Lalit DarPreeti Bharaj

Harendra Singh ChaharDepartment of Microbiology,

All India Institute of Medical Sciences,New Delhi, India

Randeep GuleriaDepartment of Medicine,

All India Institute of Medical Sciences,New Delhi, India

cal Virology 40 (2007) 87–88

Sushil K. KabraDepartment of Pediatrics,

All India Institute of Medical Sciences,New Delhi, India

Shobha Broor ∗Department of Microbiology,

All India Institute of Medical Sciences,New Delhi, India

∗ Corresponding author. Mobile: +91 9811873410;fax: +91 11 26588663.

E-mail addresses: ap [email protected] (A. Pandey),[email protected] (K. Diddi), [email protected]

(L. Dar),[email protected] (P. Bharaj),

[email protected] (H.S. Chahar),[email protected] (R. Guleria),

[email protected] (S.K. Kabra),[email protected] (S. Broor)

21 March 2007